Quanterix (QTRX) Return on Capital Employed (2018 - 2026)
Quanterix (QTRX) reported Return on Capital Employed of 41.0% for Q1 2026, down 2332.0% on a YoY basis from 1.84% in Q1 2025, and down 16.48% quarter-over-quarter from 35.2% in Q4 2025.
Quanterix (QTRX) Return on Capital Employed (2018 - 2026) Analysis & Trends
Quanterix has reported Return on Capital Employed for 9 years, with the latest figure at 41.0% in Q1 2026.
- For the quarter ending Q1 2026, Return on Capital Employed fell 2332.0% year-over-year to 41.0%; the trailing twelve-month figure through Mar 2026 stood at 41.0% (down 2332.0% YoY), and the FY2025 full-year result was 37.15%, down 2314.0% from the prior year.
- Return on Capital Employed for Q1 2026 stood at 41.0%, down from 35.2% in the prior quarter.
- The five-year high for Return on Capital Employed was 11.8% in Q4 2023, with the low at 41.0% in Q1 2026.
- Historically, Return on Capital Employed has averaged 21.11% across 5 years, with a median of 17.67% in 2025.
- Annual changes were most pronounced in 2023 — Return on Capital Employed surged 1375 bps — and 2026, when it slumped 2332 bps.
- Quanterix's Return on Capital Employed stood at 25.54% in 2022, then jumped by 54 bps to 11.8% in 2023, then decreased by 22 bps to 14.35% in 2024, then sank by 145 bps to 35.2% in 2025, then slipped by 16 bps to 41.0% in 2026.
- The last three Return on Capital Employed figures came in at 41.0% (Q1 2026), 35.2% (Q4 2025), and 34.75% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 7.36% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 11.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 10.45% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 24.24% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 9.30% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 11.57% |
| 10 | Quanterix | 159.26 Mn | 59.99 Mn | 15.57 Mn | -41.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -41.00% |
| Dec 31, 2025 | -35.20% |
| Sep 30, 2025 | -34.75% |
| Jun 30, 2025 | -26.63% |
| Mar 31, 2025 | -17.67% |
| Dec 31, 2024 | -14.35% |
| Sep 30, 2024 | -13.65% |
| Jun 30, 2024 | -13.94% |
| Mar 31, 2024 | -13.01% |
| Dec 31, 2023 | -11.80% |
| Sep 30, 2023 | -13.69% |
| Jun 30, 2023 | -20.01% |
| Mar 31, 2023 | -24.09% |
| Dec 31, 2022 | -25.54% |
| Sep 30, 2022 | -22.98% |
| Jun 30, 2022 | -16.92% |
| Mar 31, 2022 | -13.69% |
| Dec 31, 2021 | -12.05% |
| Sep 30, 2021 | -9.96% |
| Jun 30, 2021 | -6.31% |